Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1997-09-30
1999-11-23
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424451, A61K 920, A61K 948
Patent
active
059895888
ABSTRACT:
A method for preventing heartburn episodes in a patient at risk to development of heartburn, comprising administering to the patient, following the heartburn inducing event but prior to development of heartburn, a composition comprising a pharmaceutically effective amount of an H.sub.2 antagonist and an amount of antacid having between about 15 mEq and 46 mEq acid neutralizing capacity.
REFERENCES:
patent: 4283408 (1981-08-01), Hirata et al.
patent: 5229137 (1993-07-01), Wolfe et al.
patent: 5629026 (1997-05-01), Davis et al.
patent: 5667794 (1997-09-01), Simon et al.
Chremos, A.N., J. Clin. Gastroenterol., "Clinical Pharmacology of Famotidine: A Summary", vol. 9 (Suppl. 2), pp. 7-12 (1987).
Thompson, et al.,CMA Journal, "Heartburn and globus in apparently healthy people", vol. 126, pp. 46-48 (1982).
Laskin, et al., J. Clin. Pharmacol, "Pharmacodynamics and Dose-Response Relationship of Famotidine: A Double-Blind Randomized Placebo-Controlled Trial", vol. 33, pp. 636-639 (1993).
McCallum et al., Digestive Diseases and Sciences, "MK-208, A Novel Histamine H2-Receptor Inhibitor with Prolonged Antisecretory Effect", vol. 30(12), pp. 1139-1144 (1985).
Gitlin et al., Amer. Journal of Gastroenterology, "A multiclinic Double-Blind Dose Ranging Study Evaluating the Efficacy and . . . ", vol. 80, p. 840 (1985).
Miyoshi et al., Naika Hokan, "Clinical Evaluation of Famotidine on Acute Gastric Mucosal Lesions Associated with Acute Gastritis and . . . ", vol. 34, pp. 442-457 (1987).
Douds, Andrew C. and J. Douglas Maxwell, BMJ,(Letters), vol. 309, p. 1156 (1994).
Cooper, J.R.B., BMJ, (Letters), vol. 309, pp. 1156-1157 (1994).
Simon et al., Esophageal, Gastric, and Duodenal Disorders, "Self-Directed Treatment of Intermittent Heartburn: A Randomized . . . ", p. A181 (1994).
MSD Merck Sharp & Dohme, "PEPCID Insert".
F-D-C Reports--"The Tan Sheet" pp. 9-11, Apr. 18, 1994.
Pepcid AC Acid Control Product Monograph (published 1994).
"The Liberator . . . ", The Pharmaceutical Journal (May 7, 1994.
Database Hcaplus on STN, No. 553610 Over-The-Counter H-2, Medical Letter, 1971.
Database HCA on STN, No. 170225 Pharmaceutical Compositions, WO 9501792, 1995.
Database Hcaplus on STN, No. 142618 Pharmaceutical Compositions, WO 9501795, 1995.
Ells Tom S.
Korn Scott H.
Luber Joseph R.
McNally Gerard P.
Howard Sharon
Mc-Neil-PPC, Inc.
Merck & Co. , Inc.
Page Thurman K.
Parr Richard S.
LandOfFree
Methods and compositions for preventing and treating heartburn does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for preventing and treating heartburn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for preventing and treating heartburn will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1218484